EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders 8 months ago ByJohnIn Breaking NewsLeaders
Sanofi and Teva Unveil Strong Phase 2b Data for Duvakitug, Offering New Hope for IBD Patients 8 months ago ByJohnIn BreakthroughsClinical Trials
Roche Unveils Breakthrough Sequencing by Expansion Technology That Could Transform Clinical Genomics 8 months ago ByJohnIn Biopharma HighlightsResearch Updates
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships 8 months ago ByJohnIn DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences 8 months ago ByJohnIn AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage 8 months ago ByJohnIn Industry ConferencesLeadersPeople
FDA Greenlights Merilog—the First Insulin Aspart Biosimilar—Boosting Access and Competition in Diabetes Care 8 months ago ByJohnIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor—A Targeted Therapy First 8 months ago ByJohnIn Biopharma HighlightsBreakthroughsFDA Approvals
FDA Clears Innovative SPN-830 Apomorphine Infusion System for Advanced Parkinson’s Disease 8 months ago ByJohnIn FDA ApprovalsInnovationTechnology
FDA Clears First-ever Pentavalent Meningococcal Vaccine—A New Era in Preventing Invasive Meningococcal Disease 8 months ago ByJohnIn DealsFDA ApprovalsPharma Industry Updates
UK Advances Clinical Trial Landscape: Historic Regulation Reform Paves Way for Efficiency and Inclusivity 8 months ago ByJohnIn BreakthroughsClinical Trials
Final Analysis of TROPION-Breast01 Reveals No Overall Survival Benefit for Dato-DXd in HR+/HER2– Breast Cancer, Despite PFS Gains 8 months ago ByJohnIn Research UpdatesTop Stories
India Poised to Become Major Hub for Early-Stage Clinical Trials Amid Global Shifts 8 months ago ByJohnIn Breaking NewsClinical Trials
Grace Therapeutics’ GTx-104 IV Nimodipine Formulation Reduces Hypotension and ICU Burden in Aneurysmal Subarachnoid Hemorrhage Phase III Trial 8 months ago ByJohnIn Biopharma HighlightsBreaking NewsTop Stories
